Browse All

Current Filters

CLEAR FILTER x

TITLE

Maintenance Immunotherapy in MOGAD: Early Steroid Benefit, Dose Thresholds, and Disability Risk

Author:Trewin, Benjamin   Forcadela, Mirasol   Rocchi, Chiara   Qiu, Jessica   Chu, Melissa   Jeyakumar, Niroshan   Dela Cruz, Fionna   Andersen, Jane   Siriratnam, Pakeeran   McLean, Antonia   Yagnik, Deepti   Lizak, Nathaniel   Chan, Fiona   Hardy, Todd   Van Der Walt, Anneke   Lechner-Scott, Jeannette   Butzkueven, Helmut   Broadley, Simon   Barnett, Michael   Reddel, Stephen   Brilot, Fabienne   Dale, Russell   Huda, Saif   Kalincik, Tomas   Ramanathan, Sudarshini   

Session Name:S6: Autoimmune Neurology: NMOSD and MOGAD  

Topic:General Neurology  

Program Number:S6.001  

Author Institution:

Steroid Use after the Inaugural Attack is a Meaningful Clinical Prognosticator in Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease

Author:Tanasescu, Radu   Human, Matthew   Papathanasiou, Athanasios   Tench, Christopher   Gilmartin, Christopher   Siriratnam, Pakeeran   Rocchi, Chiara   Hargovan-Lalloo, Milan   Gran, Bruno   The, Ei Zune   Varley, James   Huda, Saif   

Session Name:P6: Autoimmune Neurology: NMOSD/MOGAD 5  

Topic:Multiple Sclerosis  

Program Number:P6.008  

Author Institution: